Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Scott Obach

Showing results (101-110 of 193) with videos related to

Pageof 20
Sort By:
Journal of Medicinal Chemistry|September 22, 2010
Aldehyde oxidase: an enzyme of emerging importance in drug discoveryDavid C Pryde, Deepak Dalvie, Qiyue Hu, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|June 25, 2013
Drug metabolites as cytochrome p450 inhibitors: a retrospective analysis and proposed algorithm for evaluation of the pharmacokinetic interaction potential of metabolites in drug discovery and developmentErnesto Callegari, Amit S Kalgutkar, Louis Leung, et al.
ACS Chemical Biology|June 22, 2017
Quantitative Chemical Proteomic Profiling of the in Vivo Targets of Reactive Drug MetabolitesLandon R Whitby, R Scott Obach, Gabriel M Simon, et al.
Protein Expression and Purification|September 10, 2020
Production of active recombinant human aldehyde oxidase (AOX) in the baculovirus expression vector system (BEVS) and deployment in a pre-clinical fraction-of-control AOX compound exposure assayCiarán N Cronin, JianHua Liu, Nicole Grable, et al.
Protein Expression and Purification|October 31, 2020
Corrigendum to 'Production of active recombinant human aldehyde oxidase (AOX) in the baculovirus expression vector system (BEVS) and deployment in a pre-clinical fraction-of-control AOX compound exposure assay' [Protein Expr. Purif. 177 (2020) 105749]Ciarán N Cronin, JianHua Liu, Nicole Grable, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|February 26, 2024
<b>Projections of Drug-Drug Interactions Caused by Time-Dependent Inhibitors of Cytochrome P450 1A2, 2B6, 2C8, 2C9, 2C19, and 2D6 Using In Vitro Data in Static and Dynamic Models</b>Elaine Tseng, Jian Lin, Timothy J Strelevitz, et al.
Journal of Medicinal Chemistry|March 31, 2018
Lead Diversification at the Nanomole Scale Using Liver Microsomes and Quantitative Nuclear Magnetic Resonance Spectroscopy: Application to Phosphodiesterase 2 InhibitorsR Scott Obach, Gregory S Walker, Raman Sharma, et al.
Clinical Pharmacokinetics|November 9, 2010
A review of the clinical pharmacokinetics and pharmacodynamics of varenicline for smoking cessationHélène M Faessel, R Scott Obach, Hans Rollema, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|December 21, 2004
Selective inhibition of human cytochrome P4502C8 by montelukastRobert L Walsky, R Scott Obach, Emily A Gaman, et al.
Chemical Research in Toxicology|March 19, 2002
Biotransformation reactions of five-membered aromatic heterocyclic ringsDeepak K Dalvie, Amit S Kalgutkar, S Cyrus Khojasteh-Bakht, et al.
Pageof 20

Showing results (101-110 of 193) with videos related to

Sort By:
Pageof 20
Journal of Medicinal Chemistry|September 22, 2010
Aldehyde oxidase: an enzyme of emerging importance in drug discoveryDavid C Pryde, Deepak Dalvie, Qiyue Hu, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|June 25, 2013
Drug metabolites as cytochrome p450 inhibitors: a retrospective analysis and proposed algorithm for evaluation of the pharmacokinetic interaction potential of metabolites in drug discovery and developmentErnesto Callegari, Amit S Kalgutkar, Louis Leung, et al.
ACS Chemical Biology|June 22, 2017
Quantitative Chemical Proteomic Profiling of the in Vivo Targets of Reactive Drug MetabolitesLandon R Whitby, R Scott Obach, Gabriel M Simon, et al.
Protein Expression and Purification|September 10, 2020
Production of active recombinant human aldehyde oxidase (AOX) in the baculovirus expression vector system (BEVS) and deployment in a pre-clinical fraction-of-control AOX compound exposure assayCiarán N Cronin, JianHua Liu, Nicole Grable, et al.
Protein Expression and Purification|October 31, 2020
Corrigendum to 'Production of active recombinant human aldehyde oxidase (AOX) in the baculovirus expression vector system (BEVS) and deployment in a pre-clinical fraction-of-control AOX compound exposure assay' [Protein Expr. Purif. 177 (2020) 105749]Ciarán N Cronin, JianHua Liu, Nicole Grable, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|February 26, 2024
<b>Projections of Drug-Drug Interactions Caused by Time-Dependent Inhibitors of Cytochrome P450 1A2, 2B6, 2C8, 2C9, 2C19, and 2D6 Using In Vitro Data in Static and Dynamic Models</b>Elaine Tseng, Jian Lin, Timothy J Strelevitz, et al.
Journal of Medicinal Chemistry|March 31, 2018
Lead Diversification at the Nanomole Scale Using Liver Microsomes and Quantitative Nuclear Magnetic Resonance Spectroscopy: Application to Phosphodiesterase 2 InhibitorsR Scott Obach, Gregory S Walker, Raman Sharma, et al.
Clinical Pharmacokinetics|November 9, 2010
A review of the clinical pharmacokinetics and pharmacodynamics of varenicline for smoking cessationHélène M Faessel, R Scott Obach, Hans Rollema, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|December 21, 2004
Selective inhibition of human cytochrome P4502C8 by montelukastRobert L Walsky, R Scott Obach, Emily A Gaman, et al.
Chemical Research in Toxicology|March 19, 2002
Biotransformation reactions of five-membered aromatic heterocyclic ringsDeepak K Dalvie, Amit S Kalgutkar, S Cyrus Khojasteh-Bakht, et al.
Pageof 20